Seite auswählen

Strong business figures for 2011 are responsible for an upswing for Evotec, the biotech company from Hamburg, in premarket trade on Tuesday. The securities at brokers Lang & Schwarz rose by 3.62 percent to 2.86 Euro at 8.55 am, whereas the total market is expected to be 0.27 percent weaker.

Evotec’s turnover for 2011 exceeded the average market expectancy as well their own expectations. The surplus was more than doubled and the company was profitable for the first time in its 18-year history.

[ilink url=““] link to source (kma-online)[/ilink]